Corient Private Wealth LLC Reduces Stock Holdings in Humana Inc. (NYSE:HUM)

Corient Private Wealth LLC reduced its stake in Humana Inc. (NYSE:HUM - Free Report) by 64.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 26,790 shares of the insurance provider's stock after selling 48,322 shares during the quarter. Corient Private Wealth LLC's holdings in Humana were worth $6,797,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Transcend Capital Advisors LLC increased its stake in shares of Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock worth $924,000 after purchasing an additional 2,914 shares during the period. FNY Investment Advisers LLC lifted its holdings in shares of Humana by 6,647.5% during the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock worth $6,916,000 after buying an additional 26,856 shares in the last quarter. Retirement Systems of Alabama boosted its position in shares of Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after acquiring an additional 192,801 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after acquiring an additional 65,735 shares in the last quarter. Finally, PDT Partners LLC increased its position in Humana by 190.0% during the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock worth $1,286,000 after acquiring an additional 2,660 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analyst Upgrades and Downgrades

HUM has been the topic of a number of recent analyst reports. Piper Sandler raised their price target on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research report on Wednesday, January 15th. Truist Financial raised their target price on Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a research report on Monday, January 6th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. StockNews.com lowered shares of Humana from a "buy" rating to a "hold" rating in a report on Tuesday, March 18th. Finally, Morgan Stanley decreased their price target on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. Eighteen analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Humana presently has a consensus rating of "Hold" and a consensus target price of $285.68.

Humana Stock Up 0.7 %

Shares of NYSE:HUM traded up $1.79 during mid-day trading on Tuesday, hitting $273.51. 1,392,561 shares of the company traded hands, compared to its average volume of 1,714,179. The stock has a 50-day moving average price of $271.01 and a two-hundred day moving average price of $275.60. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The stock has a market cap of $33.01 billion, a P/E ratio of 27.49, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.29%. Humana's dividend payout ratio is currently 35.58%.

Insider Buying and Selling at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the business's stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.37% of the company's stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.